raymond james financial inc. - RJF
RJF
Close Chg Chg %
132.19 0.53 0.40%
Open Market
132.72
+0.53 (0.40%)
Volume: 510.02K
Last Updated:
Apr 11, 2025, 11:44 AM EDT
Company Overview: raymond james financial inc. - RJF
RJF Key Data
Open $131.38 | Day Range 129.67 - 134.36 |
52 Week Range 104.24 - 174.32 | Market Cap $27.10B |
Shares Outstanding 204.91M | Public Float 184.38M |
Beta 0.96 | Rev. Per Employee N/A |
P/E Ratio 13.31 | EPS $10.51 |
Yield 135.75% | Dividend $0.50 |
EX-DIVIDEND DATE Apr 1, 2025 | SHORT INTEREST N/A |
AVERAGE VOLUME 2.01M |
RJF Performance
1 Week | 6.94% | ||
1 Month | -7.14% | ||
3 Months | -14.25% | ||
1 Year | 7.90% | ||
5 Years | 185.64% |
RJF Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
16
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
Average Recommendation | OVERWEIGHT | Average Target Price | 162.083 | |
Number of Ratings | 16 | Current Quarters Estimate | 2.50 | |
FY Report Date | 06 / 2025 | Current Year's Estimate | 10.528 | |
Last Quarter’s Earnings | 2.46 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 10.05 | Next Fiscal Year Estimate | 11.101 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 12 | 11 | 14 | 14 |
Mean Estimate | 2.50 | 2.66 | 10.53 | 11.10 |
High Estimates | 2.65 | 2.89 | 11.25 | 12.03 |
Low Estimate | 2.24 | 2.46 | 10.00 | 9.95 |
Coefficient of Variance | 4.71 | 4.99 | 3.13 | 5.49 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 5 | 5 | 6 |
OVERWEIGHT | 0 | 0 | 0 |
HOLD | 11 | 10 | 10 |
UNDERWEIGHT | 0 | 1 | 1 |
SELL | 0 | 0 | 0 |
MEAN | Overweight | Overweight | Overweight |
SEC Filings for Raymond James Financial Inc. - RJF
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Raymond James Financial Inc. - RJF
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
Mar 3, 2025 | Christopher S. Aisenbrey Chief Human Resources Officer | 14,129 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $151.73 per share | 2,143,793.17 |
Mar 3, 2025 | Christopher S. Aisenbrey Chief Human Resources Officer | 14,599 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 3, 2025 | Christopher S. Aisenbrey Chief Human Resources Officer | 1,200 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 25, 2025 | Gordon L. Johnson Director | 44,290 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 25, 2025 | Gordon L. Johnson Director | 43,948 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 25, 2025 | Gordon L. Johnson Director | 43,606 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 25, 2025 | Gordon L. Johnson Director | 42,353 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 25, 2025 | Gordon L. Johnson Director | 2,895 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 25, 2025 | Gordon L. Johnson Director | 500 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 25, 2025 | Gordon L. Johnson Director | 2,211 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 25, 2025 | Gordon L. Johnson Director | 2,553 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 25, 2025 | Gordon L. Johnson Director | 2,645 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 24, 2025 | Raymond W. McDaniel Director | 3,557 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 24, 2025 | Raymond W. McDaniel Director | 4,810 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 24, 2025 | Raymond W. McDaniel Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 24, 2025 | Roderick C. McGeary Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 24, 2025 | Roderick C. McGeary Director | 23,051 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 24, 2025 | Roderick C. McGeary Director | 21,798 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Feb 4, 2025 | Jonathan N. Santelli EVP, Gen Counsel, Secy | 22,879 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $168.25 per share | 3,849,391.75 |
Dec 18, 2024 | Steven M. Raney Executive Chair RJBank | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |